183 related articles for article (PubMed ID: 12091340)
1. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
[TBL] [Abstract][Full Text] [Related]
2. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
[TBL] [Abstract][Full Text] [Related]
3. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
4. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
5. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
6. The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation.
Capron C; Lécluse Y; Kaushik AL; Foudi A; Lacout C; Sekkai D; Godin I; Albagli O; Poullion I; Svinartchouk F; Schanze E; Vainchenker W; Sablitzky F; Bennaceur-Griscelli A; Duménil D
Blood; 2006 Jun; 107(12):4678-86. PubMed ID: 16514064
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
Goldfarb AN; Lewandowska K
Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
[TBL] [Abstract][Full Text] [Related]
8. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
[TBL] [Abstract][Full Text] [Related]
9. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
10. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
Kelliher MA; Seldin DC; Leder P
EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
[TBL] [Abstract][Full Text] [Related]
11. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
12. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade.
Condorelli GL; Tocci A; Botta R; Facchiano F; Testa U; Vitelli L; Valtieri M; Croce CM; Peschle C
Mol Cell Biol; 1997 May; 17(5):2954-69. PubMed ID: 9111367
[TBL] [Abstract][Full Text] [Related]
13. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy.
Elefanty AG; Begley CG; Metcalf D; Barnett L; Köntgen F; Robb L
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11897-902. PubMed ID: 9751762
[TBL] [Abstract][Full Text] [Related]
15. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
[TBL] [Abstract][Full Text] [Related]
16. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
17. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
18. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision.
Han H; Tanigaki K; Yamamoto N; Kuroda K; Yoshimoto M; Nakahata T; Ikuta K; Honjo T
Int Immunol; 2002 Jun; 14(6):637-45. PubMed ID: 12039915
[TBL] [Abstract][Full Text] [Related]
19. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
20. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
